期刊文献+

碘131与甲巯咪唑对甲状腺眼病发展的影响 被引量:12

暂未订购
导出
摘要 目的:用循证医学方法评估碘131和甲巯咪唑治疗甲亢时对甲状腺眼病的影响,为甲亢的治疗提供依据。方法:检索至2012年2月的Cochrane图书馆、Embase、PubMed等的文献资料,搜集用碘131或甲巯咪唑治疗成人甲亢的临床对照试验,评价其质量,用Revman软件对其行Meta分析。结果:最终纳入3个随机对照实验。结果显示眼病的新发及恶化人数,碘131组较多,差异有统计学意义(P<0.000 01);需激素或放疗的人数,碘131组较多,差异有统计学意义(P=0.007)。结论:碘131较甲巯咪唑更易引起眼病发展和恶化。
出处 《广西医科大学学报》 CAS 2012年第3期414-417,共4页 Journal of Guangxi Medical University
  • 相关文献

参考文献9

  • 1Hadas S-K, Eyal R, Murat H, et al. Treatment modali-ties for Graves" ophthalmopathy: systematic review and metaanalysis[J]. J Clin Endoerinol Metab, 2009,94 (8) 2 708-2 716.
  • 2Bahn RS. Graves' ophthalmopathy[J]. The New Eng- land Journal of Medicine, 2010,362 : 726-738.
  • 3Acharya SH, Avenell A, Philip S. Radioiodine therapy (RAI) for Graves disease (GD) and the effect on oph- thalmopathy., a systematic review[J]. Clinical Endocri- nology, 2008,69 : 943-950.
  • 4Stewart LA, Clarke MJ. Practical methodology of meta analyses (overviews) using updated individual patient data[J].Statistics in Medicine,1995,14:2 057-2 079.
  • 5Higgins JPT,Thompson SG, Deeks J J, et al. Measuring inconsistency in metaanalyses[J]. BMJ, 2003,327 : 557- 560.
  • 6Traisk F, Tallstedt L, Abraham-Nordling M, et al. Thy-roid-associated ophthalmopathy after treatment for Graves" hyperthyroidism with antithyroid drugs or io- dine-131[J]. J Clin Endoerinol. Metab, 2009,94(10): 3 700-3 707.
  • 7Tallstedt L, Lundell G, Torring O, et al. Occurrence ot ophthalmopathy after treatment for Graves' hyperthy- roidism[J]. The New England Journal of Medicine, 1992,326:1 733-1 738.
  • 8Bartalena L, Marcocci C, Bogazzi F, et al. Relation be- tween therapy for hyperthyroidism and the course of Graves" ophthalmopathy[J].The New England Journal of Medicine, 1998,338(2) :73-78.
  • 9Ponto KA, Zang S, Kahaly GJ. The tale of radioiodine and Graves" orbitopathy[J]. Thyroid, 2010,20 (7) : 785- 793.

同被引文献100

引证文献12

二级引证文献112

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部